Veristat

Veristat, founded in 1994, operates as a science-focused, full-service clinical research organization (CRO). The company specializes in supporting clinical trials and regulatory submissions for pharmaceutical, biotechnology, and medical device firms. With a reported revenue of $105.2M and an employee range of 500-1,000 employees, Veristat demonstrates significant operational capacity. Its core expertise encompasses critical areas of clinical development, including data management, medical writing, programming, and project management, providing comprehensive support for clients' complex needs. Veristat's consultative approach and commitment to scientific rigor are central to its mission of advancing healthcare innovation.

The organization's operational strength is derived from its experienced team and robust service delivery model. Veristat leverages deep industry knowledge to effectively manage the intricacies of drug and device development, aiming to expedite client progress from discovery to market. Recognizing the importance of its personnel, the company offers insights into its professional structure. Meet Veristat's team to discover the dedicated experts driving healthcare solutions through collaborative efforts and specialized skills.

Veristat's strategic guidance and execution capabilities are further highlighted by its financial performance and market positioning. The company has secured funding, including a $2.0M debt round in April 2020, to support its growth and operational expansion. For a detailed overview of its financial trajectory and performance metrics, interested parties can Explore financial highlights. Veristat competes within a dynamic CRO landscape, offering specialized services that address the evolving demands of global healthcare innovation and regulatory compliance.